qSOFA-positive (≥ 2) | qSOFA-negative (< 2) | p value | |
---|---|---|---|
(N = 159) | (N = 26) | ||
Primary site of infection (%) | |||
Bloodstream | 29 (18.2%) | 8 (30.8%) | 0.094 |
Respiratory | 31 (19.5%) | 3 (11.5%) | 0.573 |
Gastrointestinal | 25 (15.7%) | 4 (15.4%) | 0.770 |
Neurological | 2 (1.3%) | 0 (0.0%) | NA |
Genitourinary | 39 (24.5%) | 6 (23.1%) | 1.000 |
Musculoskeletal | 19 (11.9%) | 1 (3.8%) | 0.476 |
Other | 14 (8.8%) | 4 (15.4%) | 0.290 |
Type of organisms (%) | |||
Gram-negative bacterial infection | 66 (41.5%) | 11 (42.3%) | |
Escherichia coli | 30 (18.9%) | 5 (19.2%) | 1.000 |
Klebsiella pneumoniae | 12 (7.5%) | 1 (3.8%) | 0.697 |
Pseudomonas aeruginosa | 7 (4.4%) | 0 (0.0%) | NA |
Gram-positive bacterial infection | 32 (20.1%) | 6 (23.1%) | |
Staphylococcus aureus | 14 (8.8%) | 4 (15.4%) | 0.290 |
Streptococcus pneumoniae | 9 (5.7%) | 0 (0.0%) | NA |
Streptococcus species | 4 (2.5%) | 1 (3.8%) | 0.535 |
Polymicrobial infection | 20 (12.6%) | 4 (15.4%) | 0.752 |
Fungal infection | 4 (2.5%) | 0 (0.0%) | NA |
Not specified | 37 (23.3%) | 5 (19.2%) | 0.803 |